Viking Therapeutics (VKTX) News Today $22.22 +0.70 (+3.25%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$22.20 -0.02 (-0.09%) As of 04/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Viking Therapeutics (NASDAQ:VKTX) Shares Down 0.4% - What's Next?Viking Therapeutics (NASDAQ:VKTX) Shares Down 0.4% - Time to Sell?April 12 at 3:24 PM | marketbeat.comQuinn Opportunity Partners LLC Makes New $3.38 Million Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX)Quinn Opportunity Partners LLC purchased a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 83,889 shares of the biotechnology company's stock, valuedApril 12 at 7:52 AM | marketbeat.comRussell Investments Group Ltd. Sells 143,854 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Russell Investments Group Ltd. lessened its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 35.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 262,163 shares of the biotecApril 12 at 4:30 AM | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Purchased by Geode Capital Management LLCGeode Capital Management LLC raised its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 0.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,880,713 shares of the biotechnology companApril 12 at 4:03 AM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Down 7.5% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Shares Down 7.5% - Here's WhyApril 11 at 2:54 PM | marketbeat.comLPL Financial LLC Increases Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX)LPL Financial LLC increased its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 18.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 96,702 shares of the biotechnology company's stoApril 11 at 3:39 AM | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Up 1.8% - Time to Buy?Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 1.8% - Here's What HappenedApril 10 at 2:11 PM | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Purchased by Fmr LLCFmr LLC grew its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 0.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,715,438 shares of the biotechnology company's stock afterApril 10 at 5:45 AM | marketbeat.comWill Viking Therapeutics Be a Top Healthcare Stock in 10 Years?April 10 at 5:07 AM | fool.comWill Viking Therapeutics Be a Top Healthcare Stock in 10 Years?April 10 at 5:07 AM | fool.comViking Therapeutics (NASDAQ:VKTX) Earns Neutral Rating from Analysts at The Goldman Sachs GroupApril 10 at 3:13 AM | americanbankingnews.comViking Therapeutics (NASDAQ:VKTX) Trading Down 1.7% - Time to Sell?Viking Therapeutics (NASDAQ:VKTX) Shares Down 1.7% - Here's WhyApril 9, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Coverage Initiated at The Goldman Sachs GroupThe Goldman Sachs Group began coverage on shares of Viking Therapeutics in a research report on Tuesday. They set a "neutral" rating and a $30.00 price objective for the company.April 9, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Hits New 1-Year Low - Here's WhyViking Therapeutics (NASDAQ:VKTX) Sets New 12-Month Low - Here's What HappenedApril 9, 2025 | marketbeat.comGoldman Sachs Initiates Coverage of Viking Therapeutics (VKTX) with Neutral RecommendationApril 9, 2025 | msn.comCalifornia Public Employees Retirement System Has $5.50 Million Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)California Public Employees Retirement System cut its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 25.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 136,592 shares of the biotechnology comApril 9, 2025 | marketbeat.comSei Investments Co. Sells 15,486 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Sei Investments Co. trimmed its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 41.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 21,451 shares of the biotechnology company's stApril 9, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Down 5.2% - Here's WhyViking Therapeutics (NASDAQ:VKTX) Stock Price Down 5.2% - Should You Sell?April 8, 2025 | marketbeat.comViking Therapeutics initiated with a Neutral at Goldman SachsApril 8, 2025 | markets.businessinsider.comViking Therapeutics draws Neutral rating at Goldman Sachs on competitive headwindsApril 8, 2025 | msn.comTrexquant Investment LP Takes $2.61 Million Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Trexquant Investment LP purchased a new position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 64,908 shares of the biotechnology company's stockApril 8, 2025 | marketbeat.comThoroughbred Financial Services LLC Sells 16,051 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Thoroughbred Financial Services LLC trimmed its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 71.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 6,373 shares of the biotechnology company's stock after selling 16April 7, 2025 | marketbeat.comSchroder Investment Management Group Has $2.39 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Schroder Investment Management Group lowered its stake in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 39.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 59,994 shares of the biotechnology company'April 7, 2025 | marketbeat.comRhenman & Partners Asset Management AB Reduces Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Rhenman & Partners Asset Management AB reduced its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 12.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,000 shaApril 6, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Purchased by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA lifted its position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 446.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,357,241 shares of thApril 6, 2025 | marketbeat.comAlliancebernstein L.P. Increases Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Alliancebernstein L.P. boosted its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 7.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,115,068 shares of the biotechnolApril 6, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 6.9% - Time to Sell?Viking Therapeutics (NASDAQ:VKTX) Shares Down 6.9% - Here's What HappenedApril 5, 2025 | marketbeat.comNorges Bank Takes Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)Norges Bank acquired a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,278,928 shares of the biotechnology company's stock, valuApril 5, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 4% - Here's What HappenedViking Therapeutics (NASDAQ:VKTX) Trading Down 4% - What's Next?April 4, 2025 | marketbeat.comCinctive Capital Management LP Has $265,000 Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Cinctive Capital Management LP decreased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 89.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 6,575 shares of the biotechnology company's stock after selling 58,505 shares duApril 4, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Director Buys $29,946.00 in StockViking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) Director Sarah Kathryn Rouan bought 1,240 shares of the stock in a transaction that occurred on Monday, March 31st. The stock was acquired at an average price of $24.15 per share, for a total transaction of $29,946.00. Following the acquisition, the director now directly owns 1,240 shares in the company, valued at $29,946. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.April 3, 2025 | marketbeat.comThe Smartest Biotech Stocks to Buy With $50April 3, 2025 | fool.comSarah Kathryn Rouan Purchases 1,240 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) StockApril 3, 2025 | insidertrades.com21,551 Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX) Bought by Nomura Asset Management Co. Ltd.Nomura Asset Management Co. Ltd. bought a new stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 21,551 shares of the biotechnology company's stock, valued at approApril 3, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Buys New Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 10,000 shares of the biotechnology company's stock, valuApril 3, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Sets New 12-Month Low - Time to Sell?Viking Therapeutics (NASDAQ:VKTX) Sets New 52-Week Low - Here's What HappenedApril 2, 2025 | marketbeat.comClearbridge Investments LLC Sells 98,456 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Clearbridge Investments LLC cut its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 13.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 640,118 shares of the biotechnology coApril 2, 2025 | marketbeat.comViking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?April 2, 2025 | fool.comViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by DnB Asset Management ASDnB Asset Management AS increased its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 98.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 30,666 shares of the biotechnology company's stock afApril 2, 2025 | marketbeat.comAmerican Century Companies Inc. Increases Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)American Century Companies Inc. boosted its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 9.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 301,582 sharApril 2, 2025 | marketbeat.comKLP Kapitalforvaltning AS Buys New Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX)KLP Kapitalforvaltning AS acquired a new position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 20,700 shares of the biotechnoApril 1, 2025 | marketbeat.comViking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past MonthMarch 31, 2025 | uk.finance.yahoo.comTraders Purchase High Volume of Call Options on Viking Therapeutics (NASDAQ:VKTX)Viking Therapeutics, Inc. (NASDAQ:VKTX - Get Free Report) was the recipient of some unusual options trading activity on Monday. Traders acquired 31,516 call options on the company. This is an increase of 87% compared to the average daily volume of 16,878 call options.March 31, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Hits New 1-Year Low - Should You Sell?Viking Therapeutics (NASDAQ:VKTX) Reaches New 1-Year Low - Time to Sell?March 31, 2025 | marketbeat.comWhich Healthcare Stock Is the Best Buy Right Now?Healthcare stocks provide a combination of upstarts with a high risk, high reward proposition to established firms that can be a defensive maneuver.March 31, 2025 | marketbeat.comPictet Asset Management Holding SA Reduces Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)Pictet Asset Management Holding SA reduced its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 9.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,237,093 shares of the biotechnology company's stocMarch 30, 2025 | marketbeat.comBlair William & Co. IL Buys 44,915 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)Blair William & Co. IL increased its stake in Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 19.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 271,869 shares of the biotechnology company's stock after purchasing an additional 44,915March 30, 2025 | marketbeat.com3VKTX : A Closer Look at Viking Therapeutics's Options Market DynamicsMarch 28, 2025 | benzinga.comBIT Capital GmbH Has $5.01 Million Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)BIT Capital GmbH trimmed its position in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 7.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 124,443 shares of the biotechnology compMarch 27, 2025 | marketbeat.comViking Therapeutics completes enrollment in Phase 2 trial of VK2735March 27, 2025 | markets.businessinsider.com Remove Ads Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VKTX Media Mentions By Week VKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼1.020.95▲Average Medical News Sentiment VKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼2816▲VKTX Articles Average Week Remove Ads Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Viatris News Today Qiagen News Today Ascendis Pharma A/S News Today Roivant Sciences News Today Lantheus News Today BridgeBio Pharma News Today TG Therapeutics News Today Revolution Medicines News Today Legend Biotech News Today Sarepta Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 4/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VKTX Stock Free VKTX Stock Alerts